1Lemann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ) [J]. J Biol Chem, 1995,270(22):12953-12956.
2Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators [J]. Nature, 1990,347(6294):645-650.
3Berer J, David EM. The mechanisms of action of PPARs [J]. Annu Rev Med, 2002,53:409-435.
4Barry GS, William JH. Recent advances in peroxisome proliferator-activated receptor science [J]. Current Med Chem, 2003,10(4):267-280.
5Jones SA, Moore LB, Shenk JL, et al. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution [J]. Mol Endocrinol, 2000,14(1):27-39.
6Robert TG, Valerie GM, Millard HL, et al. Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors [J]. Mol Cell, 2000,5(3):545-555.
7YiX GuoZR.Three dimensional quantitative structure activity relationship of PPARγ agonists[J].Acta Pharm Sin (药学学报),2001,36(4):262-268.
8Cronet P, Jens FW, Folmer R, et al. Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family [J]. Structure, 2001,9(8),699-706.
10Lee G, Elwood F, McNally J, et al. T0070907, a selective ligand for peroxisome proliferator-activated receptor γ functions as an antagonist of biochemical and cellular activities [J]. J Bio Chem, 2002,277(22):19649-19657.
